Volume 11, Issue 1 pp. 222-229
ORIGINAL RESEARCH—ENDOCRINOLOGY

Short- and Long-Term Clinical Skin Effects of Testosterone Treatment in Trans Men

Katrien Wierckx MD

Corresponding Author

Katrien Wierckx MD

Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

These authors contributed equally to this manuscript.Corresponding Author: Katrien Wierckx, MD, Department of Endocrinology, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium. Tel: +32 9 332 19 66; Fax: 0032 9 332 38 86; E-mail: [email protected]Search for more papers by this author
Fleur Van de Peer

Fleur Van de Peer

Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

These authors contributed equally to this manuscript.Search for more papers by this author
Evelien Verhaeghe MD, PhD

Evelien Verhaeghe MD, PhD

Department of Dermatology, Ghent University Hospital, Ghent, Belgium

Search for more papers by this author
David Dedecker

David Dedecker

Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Search for more papers by this author
Eva Van Caenegem MD

Eva Van Caenegem MD

Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Search for more papers by this author
Kaatje Toye

Kaatje Toye

Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Search for more papers by this author
Jean Marc Kaufman MD, PhD

Jean Marc Kaufman MD, PhD

Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Search for more papers by this author
Guy T'Sjoen MD, PhD

Guy T'Sjoen MD, PhD

Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Department of Sexology and Gender Problems, Ghent University Hospital, Ghent, Belgium

Search for more papers by this author
First published: 31 October 2013
Citations: 21

Abstract

Introduction

Our knowledge concerning the effects of testosterone (T) therapy on the skin of trans men (female-to-male transsexuals) is scarce.

Aim

The aim of this study was to evaluate the short- and long-term clinical effects of T treatment on the skin of trans men.

Methods

We conducted a prospective intervention study in 20 hormone naive trans men and a cross-sectional study in 50 trans men with an average of 10 years on T therapy.

Main Outcome Measures

Acne lesions were assessed using the Gradual Acne Grading Scale, hair patterns using the Ferriman and Gallwey classification (F&G), and androgenetic alopecia using the Norwood Hamilton Scale.

Results

T treatment increased facial and body hair growth. The F&G score increased progressively from a median value of 0.5 at baseline to a value of 12 after 12 months of T administration. After long-term T treatment, all but one trans man achieved an F&G score indicative of hirsutism in women, with a median value of 24. Only one trans man acquired mild frontotemporal hair loss during the first year of T treatment, whereas 32.7% of trans men had mild frontotemporal hair loss and 31% had moderate to severe androgenetic alopecia after long-term T therapy. The presence and severity of acne increased during the first year of T therapy, and peaked at 6 months. After long-term T treatment, most participants had no or mild acne lesions (93.9%). Dermatological outcome was not demonstrably related to individual serum T or dihydrotestosterone levels.

Conclusions

T treatment increased facial and body hair in a time-dependent manner. The prevalence and severity of acne in the majority of trans men peaked 6 months after beginning T therapy. Severe skin problems were absent after short- and long-term T treatment. Wierckx K, Van de Peer F, Verhaeghe E, Dedecker D, Van Caenegem, E, Toye K, Kaufman JM, and T'Sjoen G. Short- and long-term clinical skin effects of testosterone treatment in trans men. J Sex Med 2014;11:222–229.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.